UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
(Exact Name of Registrant as Specified in its Charter)
(State or Other Jurisdiction of Incorporation or Organization) | (Commission File No.) | (I.R.S. Employer Identification No.) |
(Address of principal executive offices and zip code)
(Registrant’s telephone number, including area code)
(Former name or former address, if changed from last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol (s) | Name of each exchange on which registered | ||
The Stock Market LLC | ||||
The Stock Market LLC | ||||
The Stock Market LLC |
Item 8.01. | Other Events. |
As previously disclosed on a Form 8-K filed by Edoc Acquisition Corp. (the “Company”) on November 13, 2020, as amended, in connection with the Company’s initial public offering, the Company entered into a letter agreement, dated November 9, 2020, with, American Physicians LLC, the Company’s sponsor, and the officers and directors of the Company (the “Letter Agreement”). The Letter Agreement, among other things, imposed certain restrictions on Company insiders and Company securities held by such persons.
On October 25, 2021, Christine Zhao, Chief Financial Officer of the Company, and I-Bankers Securities, Inc. entered into a waiver agreement (the “Insider Waiver Letter”) to partially waive Ms. Zhao’s compliance with Section 15 of the Letter Agreement with respect to her ability to become involved in a third blank check company prior to the Company’s announcement of an agreement to conduct a business combination. A copy of the form of Insider Waiver Letter is attached as Exhibit 10.1 hereto and is incorporated by reference herein.
Item 9.01 | Financial Statements and Exhibits. |
(d) | Exhibits |
EXHIBIT INDEX
Exhibit No. | Description | |
10.1 | Waiver Letter dated October 25, 2021 by and among the Company, Christine Zhao, and I-Bankers Securities, Inc. | |
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
1
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EDOC ACQUISITION CORP. | ||
Date: October 25, 2021 | ||
By: | /s/ Kevin Chen | |
Kevin Chen Chief Executive Officer |
2